Related Experiment Video
Updated: Mar 10, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.3K
Is There a Role for Genetic Information in Risk Assessment and Decision Making in Prostate Cancer?
Mohamadreza Nowroozi1, Mohsen Ayati1, Erfan Amini1
1Uro-Oncology Research Center (UORC), Tehran University of Medical Sciences, Tehran, Iran.
Nephro-Urology Monthly
|December 10, 2016
Summary
Decreased expression of the AMACR gene in prostate cancer indicates a poorer prognosis. This finding aids in risk assessment and treatment planning for prostate cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer exhibits variable clinical behavior, prompting research into genetic markers for risk stratification.
- The utility of inherited genetic information in prostate cancer management remains debated.
- Key genes like NKX3.1, AMACR, TMPRSS2-ERG, ERG, and SPINK1 are investigated for their roles.
Purpose of the Study:
- To investigate the correlation between clinical parameters of prostate cancer (PSA, Gleason score, metastasis) and the expression of specific genes.
- To evaluate the potential of gene expression patterns in predicting prostate cancer outcomes.
Main Methods:
- Analysis of 43 prostate cancer tissue samples (34 radical prostatectomy, 9 needle biopsy).
- Gene expression levels of NKX3.1, AMACR, TMPRSS2-ERG, ERG, and SPINK1 were quantified using real-time PCR.
- Correlation analysis between gene expression and clinical parameters (PSA, Gleason score, metastasis).
Main Results:
- No significant correlation was found between the expression of the studied genes and PSA levels or Gleason scores.
- A statistically significant decrease in AMACR gene expression was observed in metastatic prostate cancer (P = 0.02).
- Expression levels of other investigated genes did not differ between metastatic and non-metastatic tumors (P > 0.1).
Conclusions:
- Decreased AMACR expression is associated with metastatic prostate cancer and may serve as a poor prognostic indicator.
- Integrating genetic information with clinical data can enhance prostate cancer risk assessment and treatment strategies.
Related Concept Videos
02:59Cancer Prevention
8.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.6K
01:28Human Genetics
1.8K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K
01:11Genome-wide Association Studies-GWAS
16.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.4K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
60
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
01:29Pharmacogenomics: Identification of New Drug Targets
57
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
57
01:33Cancer-Critical Genes I: Proto-oncogenes
11.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K